Equipment supply for oncology study

Why it matters

What equipment do oncology trials need for cell and gene therapy cold chain supply?
Oncology cell and gene therapy trials need ultra-low temperature freezers, cryogenic shippers, and continuous temperature dataloggers with real-time alerting, plus validated chain-of-custody documentation from manufacture through to dosing. Oncology is now the leading disease area for cell and gene therapy development, with thousands of CAR-T and related therapies in active trials worldwide*. Many of these products must be kept at or below −120°C, with some protocols specifying −150°C**, and “vein-to-vein” timelines measured in hours rather than days. A single cold chain failure — a freezer left unplugged, a delayed courier — can mean a lost dose and a delayed treatment cycle for a patient***. Woodley Trial Solutions supplies this equipment, calibrated and ready, so your CGT supply chain is held to the same standard as the therapy itself.

Toxicity monitoring drives the equipment list
Oncology protocols are built around managing dose-limiting toxicities: myelosuppression tracked through CBC analysis, hepatotoxicity through liver function panels, renal function through further blood chemistry. In immuno-oncology studies, immune-related adverse events can escalate quickly and often require rapid, on-site results to guide same-visit dosing decisions. This is why POCT plays a bigger role in oncology than in almost any other therapeutic area. We supply CBC analysers, chemistry panels, and coagulation and blood gas devices, fully calibrated and ready for site use.

Cardiac safety monitoring is close to universal
A large share of oncology compounds — particularly targeted therapies and tyrosine kinase inhibitors — carry a QT-prolongation safety signal. Few other therapeutic areas build cardiac safety monitoring into the protocol this consistently. We supply and calibrate ECG devices as standard, alongside our POCT and vital signs monitoring equipment.

Basket, umbrella, and adaptive designs change what you need, mid-trial
Oncology increasingly runs as basket, umbrella, or adaptive trials, with multiple sub-studies and arms under one master protocol, and site lists that shift as the trial evolves. Equipment needs change accordingly — sometimes site by site, sometimes arm by arm. Our global distribution network and rental model are built for that kind of movement, so equipment can flex with the protocol rather than lag behind it.

Patient burden is pushing more decentralised elements into oncology
Oncology patients are often too unwell, or too far from a trial site, for frequent visits to be practical. That's pushing more oncology sponsors toward decentralised elements — home health visits, local blood draws, wearable and remote monitoring. We supply the digital health technology and POCT devices that decentralised oncology models depend on, alongside site-based equipment, so you can run a hybrid model without gaps.

What we do

Our global distribution network puts calibrated equipment on site for oncology studies anywhere in the world, whenever it's needed. Cold chain and cell therapy supply covers ultra-low temperature freezers, cryogenic shippers, and temperature dataloggers. Toxicity and safety monitoring covers POCT blood analysers, chemistry panels, and ECG equipment. Day-to-day site operations covers centrifuges, infusion pumps, blood pressure monitors, refrigerators, freezers, thermometers, and scales. Everything is available fully calibrated and ready to use. If you require equipment supply for an oncology study, get in touch.